Status:
COMPLETED
Nicotine and Tobacco Message Framing Among LGBT Young Adults
Lead Sponsor:
Ohio State University Comprehensive Cancer Center
Collaborating Sponsors:
National Institutes of Health (NIH)
National Cancer Institute (NCI)
Conditions:
Tobacco-Related Carcinoma
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
This trial refines and evaluates how cultural targeting influences the effectiveness of anti-tobacco messages among lesbian, gay, bisexual, and transgender (LGBT) young adults at risk for the use of m...
Detailed Description
The goal of this study is to identify if culturally targeted (CT) or non-targeted (NT) anti-polytobacco messages are most effective for engaging LGBT consumers. Using the most effective NT messages fr...
Eligibility Criteria
Inclusion
- Speaks English fluently
- Self-identifies as lesbian, gay, bisexual, transgender, queer, or another non- heterosexual orientation or non-binary gender identity
- Ever used e-cigarettes AND combustible cigarettes
- Currently uses e-cigarettes, combustible cigarettes, or both e-cigarettes and combustible cigarettes
- Resides in the United States
- Access to a laptop or desktop computer with a camera for virtual eye-tracking
Exclusion
- Glaucoma
- Cataracts
Key Trial Info
Start Date :
June 19 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 6 2024
Estimated Enrollment :
252 Patients enrolled
Trial Details
Trial ID
NCT05972941
Start Date
June 19 2023
End Date
February 6 2024
Last Update
June 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ohio State University
Columbus, Ohio, United States, 43210